Unraveling heterogeneity in pediatric atopic dermatitis: Identification of serum biomarker based patient clusters.

J Allergy Clin Immunol

National Expertise Center for Atopic Dermatitis, Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands. Electronic address:

Published: January 2022

Background: Increasing evidence shows that pediatric atopic dermatitis (AD) differs from adult AD on a biologic level. Broad biomarker profiling across a wide range of ages of pediatric patients with AD is lacking.

Objective: Our aim was to identify serum biomarker profiles in children with AD aged 0 to 17 years and compare these profiles with those previously found in adults with AD.

Methods: Luminex multiplex immunoassays were used to measure 145 biomarkers in serum from 240 children with AD (aged 0-17 years). Principal components analysis followed by unsupervised k-means clustering were performed to identify patient clusters. Patients were stratified into age groups (0-4 years, 5-11 years, and 12-17 years) to assess association between age and cluster membership.

Results: Children aged 0 to 4 years had the highest levels of T1 cell-skewing markers and lowest levels of T17 cell-related markers. T2 cell-related markers did not differ significantly between age groups. Similar to the pattern in adults, cluster analysis identified 4 distinct pediatric patient clusters (T2 cell/retinol-dominant, skin-homing-dominant, T1 cell/T2 cell/T17 cell/IL-1-dominant, and T1 cell/IL-1/eosinophil-inferior clusters). Only the T1 cell/T2 cell/T17 cell/IL-1-dominant cluster resembled 1 of the previously identified adult clusters. Although no association with age or age of onset seemed to be found, disease severity was significantly associated with the skin-homing-dominant cluster.

Conclusion: Four distinct patient clusters based on serum biomarker profiles could be identified in a large cohort of pediatric patients with AD, of which 1 was similar to previously identified adult clusters. The identification of endotypes driven by distinct underlying immunopathologic pathways might be useful to define pediatric patients with AD who are at risk of persistent disease and may necessitate different targeted treatment approaches.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaci.2021.06.029DOI Listing

Publication Analysis

Top Keywords

patient clusters
16
serum biomarker
12
pediatric patients
12
children aged
12
pediatric atopic
8
atopic dermatitis
8
biomarker profiles
8
aged years
8
age groups
8
association age
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!